Sophia Bird

1PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Jan 27, 2025
A cationic liposome-formulated Toll Like Receptor (TLR)7/8 agonist enhances the efficacy of a vaccine against fentanyl toxicity.

Fatima A Hamid, Nguyet-Minh Nguyen Le, Daihyun Song

Pageof 1

Frequent Collaborators

1 joint publications

Fatima A Hamid

1 joint publications

Nguyet-Minh Nguyen Le

1 joint publications

Daihyun Song

1 joint publications

Hardik Amin

1 joint publications

Linda Hicks

1 joint publications

Karthik Siram

1 joint publications

Brooke Hoppe

1 joint publications

Borries Demeler

1 joint publications

Jay T Evans

1 joint publications

David Burkhart

Frequent Collaborators

1 joint publications

Fatima A Hamid

1 joint publications

Nguyet-Minh Nguyen Le

1 joint publications

Daihyun Song

1 joint publications

Hardik Amin

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Published on : Mar 16, 2022

1.7K
See more related videos

Top Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from <em>Chlamydia muridarum</em> for Vaccine Development

Published on : Mar 16, 2022

1.7K
See more related videos